ArticlePloS one2017

Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.

Johannes Ettl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.